
Originally discovered in the intestine of silkworms, the proteolytic enzyme Serrapeptase is harnessed by Arthur Andrew Medical through the isolation of the microorganism, Serratia E-15. Serrapeptase’s inherent ability to digest dead tissue enables the enzyme to successfully aid in degenerating scar tissue, cysts, blood clots, arterial plaque and allows for more fluid and natural blood flow throughout the body.
Serracel has a variety of different benefits that may help with the following: